12/3
07:00 am
carl
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting
High
Report
Carlsmed Announces U.S. Launch of its aprevo® Technology Platform for Cervical Fusion Surgeries at the Cervical Spine Research Society (CSRS) 53rd Annual Meeting
11/25
01:49 pm
carl
Carlsmed (NASDAQ:CARL) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Carlsmed (NASDAQ:CARL) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
11/19
04:13 pm
carl
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
Low
Report
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference [Yahoo! Finance]
11/19
04:01 pm
carl
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
Low
Report
Carlsmed, Inc. To Participate in the Piper Sandler 37th Annual Healthcare Conference
11/15
01:42 am
carl
Medium
Report
11/7
11:09 am
carl
Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $20.00 price target on the stock, up previously from $18.00.
Low
Report
Carlsmed (NASDAQ:CARL) had its "buy" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $20.00 price target on the stock, up previously from $18.00.
11/7
08:07 am
carl
Carlsmed (NASDAQ:CARL) had its price target raised by analysts at BTIG Research from $21.00 to $24.00. They now have a "buy" rating on the stock.
High
Report
Carlsmed (NASDAQ:CARL) had its price target raised by analysts at BTIG Research from $21.00 to $24.00. They now have a "buy" rating on the stock.
11/6
05:27 pm
carl
Carlsmed, Inc. GAAP EPS of -$0.40 beats by $0.02, revenue of $13.1M beats by $1.72M [Seeking Alpha]
High
Report
Carlsmed, Inc. GAAP EPS of -$0.40 beats by $0.02, revenue of $13.1M beats by $1.72M [Seeking Alpha]
11/6
04:01 pm
carl
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
High
Report
Carlsmed Reports Third Quarter 2025 Financial Results and Raises Full-Year Guidance
10/23
04:01 pm
carl
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
Medium
Report
Carlsmed Inc. to Report Third Quarter 2025 Financial Results on November 6, 2025
10/16
12:32 pm
carl
Carlsmed (NASDAQ:CARL) is now covered by analysts at
Weiss Ratings. They set a "sell (e)" rating on the stock.
Low
Report
Carlsmed (NASDAQ:CARL) is now covered by analysts at
Weiss Ratings. They set a "sell (e)" rating on the stock.
9/29
09:00 am
carl
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary
Medium
Report
Carlsmed, Inc. Appoints Jennifer Kamocsay as Chief Legal Officer and Secretary
9/22
09:08 am
carl
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index [Yahoo! Finance]
Low
Report
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index [Yahoo! Finance]
9/22
09:00 am
carl
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index
Medium
Report
Carlsmed, Inc. Selected for Inclusion in Russell 2000® Index